Rein Therapeutics, Inc. Depreciation
Rein Therapeutics, Inc. (RNTX) reported Depreciation of $49.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2024-04-15
- Rein Therapeutics, Inc. depreciation for the quarter ending 2023-12-31 was $12.00K, a 90.40% decline year-over-year.
- Rein Therapeutics, Inc. depreciation for the quarter ending 2023-09-30 was $12.00K, a 20.00% decline year-over-year.
- Rein Therapeutics, Inc. depreciation for the quarter ending 2023-06-30 was $12.00K, a 14.29% decline year-over-year.
- Rein Therapeutics, Inc. depreciation for the quarter ending 2023-03-31 was $13.00K, a 13.33% decline year-over-year.
- Rein Therapeutics, Inc. depreciation for fiscal 2023 was $49.00K, a 71.01% decline from fiscal 2022.
- Rein Therapeutics, Inc. depreciation for fiscal 2022 was $169.00K, a 39.67% increase from fiscal 2021.
- Rein Therapeutics, Inc. depreciation for fiscal 2021 was $121.00K, a 25.77% decline from fiscal 2020.
- Rein Therapeutics, Inc. depreciation for fiscal 2020 was $163.00K, a 16.43% increase from fiscal 2019.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month |
|---|---|---|---|---|---|
| 2023-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-15 | $24.00K derived: sum of 2 quarters · filed 2024-04-15 | $36.00K derived: sum of 3 quarters · filed 2024-04-15 | $49.00K 10-K · filed 2024-04-15 | |
| 2023-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-13 | $24.00K derived: sum of 2 quarters · filed 2023-10-13 | $37.00K 10-Q · filed 2023-10-13 | $162.00K derived: sum of 4 quarters · filed 2024-04-15 | |
| 2023-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $25.00K 10-Q · filed 2023-08-11 | $150.00K derived: sum of 3 quarters · filed 2024-04-15 | $165.00K derived: sum of 4 quarters · filed 2024-04-15 | |
| 2023-03-31 | $13.00K 10-Q · filed 2023-05-08 | $138.00K derived: sum of 2 quarters · filed 2024-04-15 | $153.00K derived: sum of 3 quarters · filed 2024-04-15 | $167.00K derived: sum of 4 quarters · filed 2024-04-15 | |
| 2022-12-31 | $125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-15 | $140.00K derived: sum of 2 quarters · filed 2024-04-15 | $154.00K derived: sum of 3 quarters · filed 2024-04-15 | $169.00K 10-K · filed 2024-04-15 | |
| 2022-09-30 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-13 | $29.00K derived: sum of 2 quarters · filed 2023-10-13 | $44.00K 10-Q · filed 2023-10-13 | $150.00K derived: sum of 4 quarters · filed 2023-10-13 | |
| 2022-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $29.00K 10-Q · filed 2023-08-11 | $135.00K derived: sum of 3 quarters · filed 2023-08-11 | $150.00K derived: sum of 4 quarters · filed 2023-08-11 | |
| 2022-03-31 | $15.00K 10-Q · filed 2023-05-08 | $121.00K derived: sum of 2 quarters · filed 2023-05-08 | $136.00K derived: sum of 3 quarters · filed 2023-05-08 | $149.00K derived: sum of 4 quarters · filed 2023-05-08 | |
| 2021-12-31 | $106.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $121.00K derived: sum of 2 quarters · filed 2023-03-20 | $134.00K derived: sum of 3 quarters · filed 2023-03-20 | $121.00K 10-K · filed 2023-03-20 | |
| 2021-09-30 | $15.00K 10-Q · filed 2021-11-12 | $28.00K derived: sum of 2 quarters · filed 2021-11-12 | $15.00K 10-Q · filed 2022-11-01 | $30.00K 10-Q · filed 2021-11-12 | $40.00K derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-06-30 | $13.00K 10-Q · filed 2021-08-11 | $15.00K 10-Q · filed 2022-08-15 | $25.00K derived: sum of 3 quarters · filed 2022-05-05 | $39.00K derived: sum of 4 quarters · filed 2022-05-05 | |
| 2021-03-31 | $2.00K 10-Q · filed 2022-05-05 | $12.00K derived: sum of 2 quarters · filed 2022-05-05 | $26.00K derived: sum of 3 quarters · filed 2022-05-05 | $95.00K derived: sum of 4 quarters · filed 2022-05-05 | |
| 2020-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $24.00K derived: sum of 2 quarters · filed 2022-03-28 | $93.00K derived: sum of 3 quarters · filed 2022-03-28 | $163.00K 10-K · filed 2022-03-28 | |
| 2020-09-30 | $14.00K 10-Q · filed 2021-11-12 | $83.00K derived: sum of 2 quarters · filed 2021-11-12 | $153.00K 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $69.00K 10-Q · filed 2021-08-11 | $139.00K 10-Q · filed 2021-08-11 | |||
| 2020-03-31 | $70.00K 10-Q · filed 2020-05-11 | ||||
| 2019-12-31 | $140.00K 10-K · filed 2021-03-24 | ||||
| 2018-12-31 | $218.00K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |